Who Paid My Doc
David Shapiro
Surgical Critical Care Hartford, CT Medical Doctor
NPI 1629278510 CMS profile 165045
1000 Asylum Ave, Suite 4320: Saint Francis Medical Group Surgeons, Hartford, CT 06105
General payments
$31,359
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, David Shapiro of Hartford, CT is reported in the CMS Open Payments database as having received $31,359 across 41 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 96th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $31,140 | 32 | |
| 2023 | General | $61 | 1 | |
| 2021 | General | $26 | 1 | |
| 2019 | General | $133 | 7 |
Beside peers
- David Shapiro
- Surgical Critical Care median
- Middle half of Surgical Critical Care
- National median
In program year 2025, general payments to David Shapiro were reported at $31,140. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.
Show as a table
| Year | David Shapiro | Surgical Critical Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $133 | $161 | $57–$631 | $163 |
| 2020 | $0 | $116 | $33–$383 | $114 |
| 2021 | $26 | $121 | $37–$475 | $132 |
| 2022 | $0 | $163 | $53–$789 | $149 |
| 2023 | $61 | $188 | $67–$1,031 | $160 |
| 2024 | $0 | $216 | $80–$1,133 | $164 |
| 2025 | $31,140 | $231 | $82–$1,489 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
28
Drug cost
$5,924
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Shingrix Varicella-Zoster Ge/As01b/Pf | Brand | 28 | $5,924 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.
Records
41 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Surgical Critical Care in Connecticut
Philip Corvo
Surgical Critical Care · Waterbury, CT
Eric Tsung
Surgical Critical Care · Bridgeport, CT
William Symons
Surgical Critical Care · Stamford, CT
Noubar Kevorkian
Surgical Critical Care · New Britain, CT
Shannon Small
Surgical Critical Care · New London, CT
Melanie Sion
Surgical Critical Care · New Haven, CT
Related records
Surgical Critical Care in Connecticut
Practitioners in the same specialty and state, ranked by reported value.
All Surgical Critical Care
Everyone recorded under this specialty, nationwide.
Doctors in Connecticut
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.